TMEM184B
Basic information
Region (hg38): 22:38219291-38273010
Previous symbols: [ "C22orf5" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TMEM184B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 13 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 13 | 2 | 0 |
Variants in TMEM184B
This is a list of pathogenic ClinVar variants found in the TMEM184B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-38221519-C-T | not specified | Uncertain significance (May 08, 2023) | ||
22-38221549-C-T | not specified | Likely benign (May 04, 2022) | ||
22-38221563-C-T | not specified | Uncertain significance (Sep 01, 2021) | ||
22-38221587-G-T | not specified | Uncertain significance (Aug 10, 2023) | ||
22-38221654-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
22-38221656-G-A | not specified | Uncertain significance (Dec 08, 2023) | ||
22-38221695-A-G | not specified | Uncertain significance (Dec 02, 2022) | ||
22-38221702-C-A | not specified | Uncertain significance (Jun 05, 2023) | ||
22-38225480-C-A | not specified | Uncertain significance (Jun 17, 2024) | ||
22-38225592-C-T | not specified | Uncertain significance (Jan 24, 2023) | ||
22-38226794-C-T | not specified | Uncertain significance (Dec 03, 2021) | ||
22-38246019-C-T | not specified | Uncertain significance (Jun 01, 2023) | ||
22-38247829-C-A | not specified | Uncertain significance (Jan 07, 2022) | ||
22-38247892-C-T | not specified | Uncertain significance (Mar 14, 2023) | ||
22-38247924-G-A | not specified | Likely benign (Mar 05, 2024) | ||
22-38247946-C-T | not specified | Uncertain significance (Apr 20, 2024) | ||
22-38247951-C-T | not specified | Uncertain significance (Jun 06, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TMEM184B | protein_coding | protein_coding | ENST00000361906 | 8 | 53743 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.373 | 0.627 | 125735 | 0 | 11 | 125746 | 0.0000437 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.06 | 165 | 258 | 0.639 | 0.0000163 | 2640 |
Missense in Polyphen | 23 | 66.401 | 0.34638 | 753 | ||
Synonymous | 0.160 | 113 | 115 | 0.981 | 0.00000865 | 790 |
Loss of Function | 3.03 | 4 | 17.8 | 0.225 | 7.57e-7 | 208 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000628 | 0.0000628 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000638 | 0.0000615 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May activate the MAP kinase signaling pathway. {ECO:0000269|PubMed:12761501}.;
Intolerance Scores
- loftool
- 0.177
- rvis_EVS
- -0.54
- rvis_percentile_EVS
- 20.54
Haploinsufficiency Scores
- pHI
- 0.337
- hipred
- Y
- hipred_score
- 0.728
- ghis
- 0.566
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.356
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tmem184b
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); muscle phenotype; cellular phenotype;
Gene ontology
- Biological process
- Cellular component
- integral component of membrane
- Molecular function